Teva Pharmaceutical Industries Ltd. (TEVA) Friday said it launched an authorized generic of Actoplus Met, or pioglitazone/metformin tablets, in US.
Actoplus met is marketed by Takeda Pharmaceuticals U.S.A Inc. and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Actoplus met had annual sales of about $413 million in the US, based on IMS sales data as of June 30, 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.